Polymeric IgA Is Superior to Monomeric IgA and IgG Carrying the Same Variable Domain in Preventing Clostridium difficile Toxin A Damaging of T84 Monolayers
Open Access
- 15 February 2000
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 164 (4) , 1952-1960
- https://doi.org/10.4049/jimmunol.164.4.1952
Abstract
The two exotoxins A and B produced by Clostridium difficile are responsible for antibiotic-associated enterocolitis in human and animals. When added apically to human colonic carcinoma-derived T84 cell monolayers, toxin A, but not toxin B, abolished the transepithelial electrical resistance and altered the morphological integrity. Apical addition of suboptimal concentration of toxin A made the cell monolayer sensitive to toxin B. Both toxins induced drastic and rapid epithelial alterations when applied basolaterally with a complete disorganization of tight junctions and vacuolization of the cells. Toxin A-specific IgG2a from hybridoma PCG-4 added apically with toxin A alone or in combination with toxin B abolished the toxin-induced epithelial alterations for up to 8 h. The Ab neutralized basolateral toxin A for 4 h, but not the mixture of the two toxins. Using an identical Ab:Ag ratio, we found that recombinant polymeric IgA (IgAd/p) with the same Fv fragments extended protection against toxin A for at least 24 h in both compartments. In contrast, the recombinant monomeric IgA counterpart behaved as the PCG-4 IgG2a Ab. The direct comparison between different Ig isotype and molecular forms, but of unique specificity, demonstrates that IgAd/p Ab is more efficient in neutralizing toxin A than monomeric IgG and IgA. We conclude that immune protection against C. difficile toxins requires toxin A-specific secretory Abs in the intestinal lumen and IgAd/p specific for both toxins in the lamina propria.Keywords
This publication has 72 references indexed in Scilit:
- Neurokinin-1 (NK-1) receptor is required in Clostridium difficile- induced enteritis.Journal of Clinical Investigation, 1998
- Clostridium difficile toxin A binding to human intestinal epithelial cellsJournal of Medical Microbiology, 1997
- INTERACTION OF ANTIGENS AND ANTIBODIES AT MUCOSAL SURFACESAnnual Review of Microbiology, 1997
- The C-terminal ligand-binding domain of Clostridium difficile toxin A (TcdA) abrogates TcdA-specific binding to cells and prevents mouse lethalityFEMS Microbiology Letters, 1997
- Immune response to Clostridium difficile infectionEuropean Journal of Gastroenterology & Hepatology, 1996
- A human antibody binds to alpha-galactose receptors and mimics the effects of Clostridium difficile toxin A in rat colonGastroenterology, 1996
- Antigenicity of amino-acid sequences from Clostridium difficile toxin BJournal of Medical Microbiology, 1996
- Effects of purified Clostridium difficile toxin A on rabbit distal colonGastroenterology, 1995
- Production of monoclonal antibody toClostridium difficiletoxin A which neutralises enterotoxicity but not haemagglutination activityFEMS Microbiology Letters, 1991
- Clostridium difficile toxin A perturbs cytoskeletal structure and tight junction permeability of cultured human intestinal epithelial monolayers.Journal of Clinical Investigation, 1988